CSF BIOMARKERS FOR THE PREDICTION OF COGNITIVE DECLINE IN ALZHEIMER'S DISEASE PATIENTS

摘要

The present invention provides a method for predicting the short-term and long-term cognitive decline in Alzheimer's disease patients and uses thereof in predicting efficacy of an AD therapeutic. The method uses baseline levels of CSF biomarkers to predict decreases over time in CAMCOG and MMSE scores.